產(chǎn)品名稱 | 乳腺癌抗雌激素耐藥蛋白1 |
英文名稱 | Anti-BCAR1 |
規(guī)格 | 0.2ml/200μg |
濃度 | 1mg/1ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱 Anti-BCAR1
中文名稱 乳腺癌抗雌激素耐藥蛋白1
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Cow, Rabbit
產(chǎn)品類型 一抗
研究領(lǐng)域 腫瘤 信號(hào)轉(zhuǎn)導(dǎo) 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 93kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from humanBCAR1
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1%BSA, 0.01M PBS, pH 7.4
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
保存條件 Store at -34 °C for oneyear.
別 名 Breast cancer anti estrogen resistance 1 protein;BCAR 1; Bcar1; BCAR1_HUMAN; Breast cancer anti estrogen resistance 1; Breastcancer anti-estrogen resistance protein 1; CAS; Cas scaffolding protein familymember 1; Crk associated substrate; Crk associated substrate p130Cas;CRK-associated substrate; CRKAS; P130CAS.
